The New World for New Drug Approvals: Evolution in Strategies for Getting FDA Drug Approvals

Pharma is adjusting rapidly to a new regulatory world: one in which post-marketing risk management plans change the relationship of the company to doctors and patients and one where FDA's expectations for pre-marketing information about product markets are likely to expand dramatically.